Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Opinion & Analysis (TSXV:VIV)

    Coverage Initiated on Maker of Antibiotic-Free Supplement for Livestock Feed

    Streetwise Reports November 27, 2019

    Sales of Antibiotic Alternative for Livestock Feed Accelerate in Asia

    Streetwise Reports November 18, 2019

    Technical Analyst: As Antibiotic Resistance Rises, So May the Stock of This Livestock Feed Company

    Streetwise Reports October 16, 2019

    5 Small-Caps on Fund Manager Steve Palmer's Radar Screen

    Streetwise Reports March 20, 2019

    Large US Market Now Open to Livestock Feed Antibiotic Replacement

    Streetwise Reports March 12, 2019

    Three Small-Caps on This Fund Manager's List

    Streetwise Reports November 1, 2018

    This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, ...

    Streetwise Reports November 1, 2018

    Update on Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

    Streetwise Reports October 30, 2018

    VIDEO: Looking to Replace Antibiotics in Livestock Feed

    BTV-Business Television August 10, 2016

    VIDEO: Developing Products to Replace Antibiotics in Livestock Feeds

    BTV-Business Television June 28, 2016

    Avivagen (V.VIV) gears to disrupt global livestock production

    Stockhouse Editorial March 4, 2015

    Avivagen (V.VIV) focuses health products on companion animal, livestock markets

    Stockhouse Editorial January 21, 2014

    Health and wellness company improves animal lives, naturally

    Stockhouse Editorial January 21, 2013